{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:21:29Z","timestamp":1788837689735,"version":"build-2803163510"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T00:00:00Z","timestamp":1422576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title\/>\n                  <jats:p>Niemann-Pick disease, type C1 (NPC1) is a familial disorder that has devastating consequences on postnatal development with multisystem effects, including neurodegeneration. There is no Food and Drug Administration-approved treatment option for NPC1; however, several potentially therapeutic compounds have been identified in assays using yeast, rodent models, and NPC1 human fibroblasts. Although these discoveries were made in fibroblasts from NPC1 subjects and were in some instances validated in animal models of the disease, testing these drugs on a cell type more relevant for NPC1 neurological disease would greatly facilitate both study of the disease and identification of more relevant therapeutic compounds. Toward this goal, we have generated an induced pluripotent stem cell line from a subject homozygous for the most frequent NPC1 mutation (p.I1061T) and subsequently created a stable line of neural stem cells (NSCs). These NSCs were then used to create neurons as an appropriate disease model. NPC1 neurons display a premature cell death phenotype, and gene expression analysis of these cells suggests dysfunction of important signaling pathways, including calcium and WNT. The clear readout from these cells makes them ideal candidates for high-throughput screening and will be a valuable tool to better understand the development of NPC1 in neural cells, as well as to develop better therapeutic options for NPC1.<\/jats:p>\n               <\/jats:sec>","DOI":"10.5966\/sctm.2014-0127","type":"journal-article","created":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T07:50:09Z","timestamp":1422690609000},"page":"230-238","source":"Crossref","is-referenced-by-count":41,"title":["Rescue of an In Vitro Neuron Phenotype Identified in Niemann-Pick Disease, Type C1 Induced Pluripotent Stem Cell-Derived Neurons by Modulating the WNT Pathway and Calcium Signaling"],"prefix":"10.1093","volume":"4","author":[{"given":"Anastasia G.","family":"Efthymiou","sequence":"first","affiliation":[{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Steiner","sequence":"additional","affiliation":[{"name":"NeuroTherapeutics Development Unit, National Institute for Neurological Diseases and Stroke, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Pavan","sequence":"additional","affiliation":[{"name":"Genetic Disease Research Branch, National Human Genome Research Institute, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Wincovitch","sequence":"additional","affiliation":[{"name":"Genetic Disease Research Branch, National Human Genome Research Institute, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Larson","sequence":"additional","affiliation":[{"name":"Genetic Disease Research Branch, National Human Genome Research Institute, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forbes D.","family":"Porter","sequence":"additional","affiliation":[{"name":"Eunice Kennedy Shriver National Institute for Child Health and Human Development, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra S.","family":"Rao","sequence":"additional","affiliation":[{"name":"Center for Regenerative Medicine, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Malik","sequence":"additional","affiliation":[{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,1,30]]},"reference":[{"key":"2021122704214091900_R1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"2021122704214091900_R2","doi-asserted-by":"crossref","first-page":"15223","DOI":"10.1073\/pnas.0808256105","article-title":"NPC1\/NPC2 function as a tag team duo to mobilize cholesterol","volume":"105","author":"Subramanian","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122704214091900_R3","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1073\/pnas.0807328105","article-title":"NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes","volume":"105","author":"Infante","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122704214091900_R4","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0960-9822(01)00396-7","article-title":"Critical role for glycosphingolipids in Niemann-Pick disease type C","volume":"11","author":"Zervas","year":"2001","journal-title":"Curr Biol"},{"key":"2021122704214091900_R5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00005072-198805000-00008","article-title":"Cerebellar involvement in murine sphingomyelinosis: A new model of Niemann-Pick disease","volume":"47","author":"Tanaka","year":"1988","journal-title":"J Neuropathol Exp Neurol"},{"key":"2021122704214091900_R6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00227765","article-title":"Cerebellar degeneration in the Niemann-Pick type C mouse","volume":"85","author":"Higashi","year":"1993","journal-title":"Acta Neuropathol"},{"key":"2021122704214091900_R7","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1073\/pnas.1014890108","article-title":"Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts","volume":"108","author":"Pipalia","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122704214091900_R8","doi-asserted-by":"crossref","first-page":"39349","DOI":"10.1074\/jbc.M112.357707","article-title":"\u03b4-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders","volume":"287","author":"Xu","year":"2012","journal-title":"J Biol Chem"},{"key":"2021122704214091900_R9","doi-asserted-by":"crossref","first-page":"e6951","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"2021122704214091900_R10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1194\/jlr.M000257","article-title":"Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid","volume":"51","author":"Liu","year":"2010","journal-title":"J Lipid Res"},{"key":"2021122704214091900_R11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1600-0854.2010.01032.x","article-title":"Lipids on trial: The search for the offending metabolite in Niemann-Pick type C disease","volume":"11","author":"Lloyd-Evans","year":"2010","journal-title":"Traffic"},{"key":"2021122704214091900_R12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ncomms1735","article-title":"Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release","volume":"3","author":"Shen","year":"2012","journal-title":"Nat Commun"},{"key":"2021122704214091900_R13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pbb.2011.12.009","article-title":"Lack of efficacy of curcumin on neurodegeneration in the mouse model of Niemann-Pick C1","volume":"101","author":"Borbon","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"2021122704214091900_R14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/nm.1876","article-title":"Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium","volume":"14","author":"Lloyd-Evans","year":"2008","journal-title":"Nat Med"},{"key":"2021122704214091900_R15","doi-asserted-by":"crossref","first-page":"e15054","DOI":"10.1371\/journal.pone.0015054","article-title":"Cyclodextrin induces calcium-dependent lysosomal exocytosis","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"key":"2021122704214091900_R16","doi-asserted-by":"crossref","first-page":"e6233","DOI":"10.1371\/journal.pone.0006233","article-title":"Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them","volume":"4","author":"Swistowski","year":"2009","journal-title":"PLoS One"},{"key":"2021122704214091900_R17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/1087057113501869","article-title":"Functional screening assays with neurons generated from pluripotent stem cell-derived neural stem cells","volume":"19","author":"Efthymiou","year":"2014","journal-title":"J Biomol Screen"},{"key":"2021122704214091900_R18","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/stem.1334","article-title":"Efficient generation of astrocytes from human pluripotent stem cells in defined conditions","volume":"31","author":"Shaltouki","year":"2013","journal-title":"Stem Cells"},{"key":"2021122704214091900_R19","doi-asserted-by":"crossref","first-page":"e96139","DOI":"10.1371\/journal.pone.0096139","article-title":"Comparison of the gene expression profiles of human fetal cortical astrocytes with pluripotent stem cell derived neural stem cells identifies human astrocyte markers and signaling pathways and transcription factors active in human astrocytes","volume":"9","author":"Malik","year":"2014","journal-title":"PLoS One"},{"key":"2021122704214091900_R20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nbt1318","article-title":"Characterization of human embryonic stem cell lines by the International Stem Cell Initiative","volume":"25","author":"Adewumi","year":"2007","journal-title":"Nat Biotechnol"},{"key":"2021122704214091900_R21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/1087057113501197","article-title":"A phenotypic compound screening assay for lysosomal storage diseases","volume":"19","author":"Xu","year":"2014","journal-title":"J Biomol Screen"},{"key":"2021122704214091900_R22","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/1087057114537378","article-title":"Niemann-Pick disease type C: Induced pluripotent stem cell-derived neuronal cells for modeling neural disease and evaluating drug efficacy","volume":"19","author":"Yu","year":"2014","journal-title":"J Biomol Screen"},{"key":"2021122704214091900_R23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ceca.2011.03.010","article-title":"Lysosomal Ca(2+) homeostasis: Role in pathogenesis of lysosomal storage diseases","volume":"50","author":"Lloyd-Evans","year":"2011","journal-title":"Cell Calcium"},{"key":"2021122704214091900_R24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1006\/bbrc.1994.1064","article-title":"The attenuated elevation of cytoplasmic calcium concentration following the uptake of low density lipoprotein in type C Niemann-Pick fibroblasts","volume":"198","author":"Yamamoto","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"2021122704214091900_R25","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1371\/journal.pone.0000019","article-title":"Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling","volume":"1","author":"Reddy","year":"2006","journal-title":"PLoS One"},{"key":"2021122704214091900_R26","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/j.1471-4159.2005.03534.x","article-title":"Defective calcium homeostasis in the cerebellum in a mouse model of Niemann-Pick A disease","volume":"95","author":"Ginzburg","year":"2005","journal-title":"J Neurochem"},{"key":"2021122704214091900_R27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ceca.2005.06.022","article-title":"Wnt and calcium signaling: Beta-catenin-independent pathways","volume":"38","author":"Kohn","year":"2005","journal-title":"Cell Calcium"},{"key":"2021122704214091900_R28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/hmg\/ddp552","article-title":"Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration","volume":"19","author":"Elrick","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2021122704214091900_R29","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1523\/JNEUROSCI.5981-10.2011","article-title":"Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder","volume":"31","author":"Lopez","year":"2011","journal-title":"J Neurosci"},{"key":"2021122704214091900_R30","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/jnr.21730","article-title":"Astrocyte-only Npc1 reduces neuronal cholesterol and triples life span of Npc1-\/- mice","volume":"86","author":"Zhang","year":"2008","journal-title":"J Neurosci Res"},{"key":"2021122704214091900_R31","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nn.2638","article-title":"Ontogeny-recapitulating generation and tissue integration of ES cell-derived Purkinje cells","volume":"13","author":"Muguruma","year":"2010","journal-title":"Nat Neurosci"},{"key":"2021122704214091900_R32","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1242\/dev.075861","article-title":"Neurogenin 2 regulates progenitor cell-cycle progression and Purkinje cell dendritogenesis in cerebellar development","volume":"139","author":"Florio","year":"2012","journal-title":"Development"},{"key":"2021122704214091900_R33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1242\/dev.120.5.1277","article-title":"Maintenance of Wnt-3 expression in Purkinje cells of the mouse cerebellum depends on interactions with granule cells","volume":"120","author":"Salinas","year":"1994","journal-title":"Development"},{"key":"2021122704214091900_R34","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.1523\/JNEUROSCI.1309-12.2012","article-title":"GSK3 temporally regulates neurogenin 2 proneural activity in the neocortex","volume":"32","author":"Li","year":"2012","journal-title":"J Neurosci"},{"key":"2021122704214091900_R35","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1016\/j.bmc.2012.08.029","article-title":"Curcumin is an inhibitor of calcium\/calmodulin dependent protein kinase II","volume":"20","author":"Mayadevi","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"2021122704214091900_R36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2741\/3250","article-title":"Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases","volume":"14","author":"Calabrese","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2021122704214091900_R37","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1213\/ANE.0b013e3181f7181c","article-title":"The cytoprotective effects of dantrolene: A ryanodine receptor antagonist","volume":"111","author":"Inan","year":"2010","journal-title":"Anesth Analg"},{"key":"2021122704214091900_R38","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1093\/hmg\/dds145","article-title":"Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts","volume":"21","author":"Yu","year":"2012","journal-title":"Hum Mol Genet"},{"key":"2021122704214091900_R39","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/00000542-199606000-00013","article-title":"Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications","volume":"84","author":"Nelson","year":"1996","journal-title":"Anesthesiology"},{"key":"2021122704214091900_R40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/biof.1065","article-title":"Molecular mechanisms of curcumin action: Signal transduction","volume":"39","author":"Shehzad","year":"2013","journal-title":"Biofactors"},{"key":"2021122704214091900_R41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ejps.2011.02.009","article-title":"Curcumin activates Wnt\/beta-catenin signaling pathway through inhibiting the activity of GSK-3beta in APPswe transfected SY5Y cells","volume":"42","author":"Zhang","year":"2011","journal-title":"Eur J Pharm Sci"},{"key":"2021122704214091900_R42","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chembiol.2003.11.010","article-title":"GSK-3-selective inhibitors derived from Tyrian purple indirubins","volume":"10","author":"Meijer","year":"2003","journal-title":"Chem Biol"},{"key":"2021122704214091900_R43","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.stemcr.2014.03.014","article-title":"Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick type C patient-specific iPS cells","volume":"2","author":"Maetzel","year":"2014","journal-title":"Stem Cell Rep"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2014-0127","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2014-0127","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/4\/3\/230\/41863643\/stcltm_4_3_230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/4\/3\/230\/41863643\/stcltm_4_3_230.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:48:42Z","timestamp":1642560522000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/4\/3\/230-238\/6397296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,30]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,1,30]]},"published-print":{"date-parts":[[2015,3,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2014-0127","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,3,1]]},"published":{"date-parts":[[2015,1,30]]}}}